Skip to content 
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified. more
| Time Frame | BIB | S&P500 |
|---|---|---|
| 1-Week Return | -3.21% | 0.01% |
| 1-Month Return | 31.84% | 3.54% |
| 3-Month Return | 26.18% | 10.58% |
| 6-Month Return | 26.5% | 8.03% |
| 1-Year Return | 100.51% | 20.06% |
| 3-Year Return | 101.18% | 70.98% |
| 5-Year Return | 7.52% | 71.89% |
| 10-Year Return | 140.42% | 252.66% |
| Stock name | Ticker | Weight |
|---|---|---|
 Net Other Assets (Liabilities) | Net.Other.Assets..Liabilities. | 38.17% |
 PROSHARES GENIUS MNY MKT ETF | IQMM | 5.79% |
 VERTEX PHARMACEUTICALS INC | VRTX | 4.4% |
 AMGEN INC | AMGN | 4.38% |
 GILEAD SCIENCES INC | GILD | 3.92% |
 REGENERON PHARMACEUTICALS | REGN | 2.65% |
 ALNYLAM PHARMACEUTICALS INC | ALNY | 1.54% |
 REVOLUTION MEDICINES INC | RVMD | 1.54% |
 BIOGEN INC | BIIB | 1.14% |
 ILLUMINA INC | ILMN | 1.11% |
 MODERNA INC | MRNA | 1.05% |
 ROIVANT SCIENCES LTD | ROIV | 1% |
 INSMED INC | INSM | 0.97% |
 ROYALTY PHARMA PLC- CL A | RPRX | 0.97% |
 ARGENX SE - ADR | ARGX | 0.94% |
 INCYTE CORP | INCY | 0.9% |
 UNITED THERAPEUTICS CORP | UTHR | 0.9% |
 GUARDANT HEALTH INC | GH | 0.82% |
 VIATRIS INC | VTRS | 0.73% |
 NEUROCRINE BIOSCIENCES INC | NBIX | 0.69% |
 BRIDGEBIO PHARMA INC | BBIO | 0.65% |
 ASCENDIS PHARMA A/S | ASND | 0.65% |
 MEDPACE HOLDINGS INC | MEDP | 0.59% |
 JAZZ PHARMACEUTICALS PLC | JAZZ | 0.59% |
 EXELIXIS INC | EXEL | 0.55% |
 MADRIGAL PHARMACEUTICALS INC | MDGL | 0.48% |
 AXSOME THERAPEUTICS INC | AXSM | 0.47% |
 SUMMIT THERAPEUTICS INC | SMMT | 0.46% |
 CYTOKINETICS INC | CYTK | 0.45% |
 BIOMARIN PHARMACEUTICAL INC | BMRN | 0.44% |
 KRYSTAL BIOTECH INC | KRYS | 0.42% |
 ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.42% |
 BIONTECH SE-ADR | BNTX | 0.41% |
 TEMPUS AI INC-CL A | TEM | 0.39% |
 SANOFI-ADR | SNY | 0.39% |
 BEONE MEDICINES LTD-ADR | ONC | 0.38% |
 KYMERA THERAPEUTICS INC | KYMR | 0.38% |
 IONIS PHARMACEUTICALS INC | IONS | 0.37% |
 NUVALENT INC-A | NUVL | 0.35% |
 PRAXIS PRECISION MEDICINES I | PRAX | 0.35% |
 HALOZYME THERAPEUTICS INC | HALO | 0.35% |
 CRINETICS PHARMACEUTICALS IN | CRNX | 0.34% |
 ALKERMES PLC | ALKS | 0.34% |
 IMMUNITYBIO INC | IBRX | 0.33% |
 SPYRE THERAPEUTICS INC | SYRE | 0.33% |
 PROTAGONIST THERAPEUTICS INC | PTGX | 0.33% |
 VAXCYTE INC | PCVX | 0.33% |
 APOGEE THERAPEUTICS INC | APGE | 0.32% |
 IMMUNOVANT INC | IMVT | 0.32% |
 ABIVAX SA-ADR | ABVX | 0.31% |
 MIRUM PHARMACEUTICALS INC | MIRM | 0.29% |
 RHYTHM PHARMACEUTICALS INC | RYTM | 0.29% |
 PTC THERAPEUTICS INC | PTCT | 0.27% |
 SCHOLAR ROCK HOLDING CORP | SRRK | 0.26% |
 XENON PHARMACEUTICALS INC | XENE | 0.26% |
 COGENT BIOSCIENCES INC | COGT | 0.26% |
 CG ONCOLOGY INC | CGON | 0.26% |
 LIGAND PHARMACEUTICALS | LGND | 0.25% |
 ERASCA INC | ERAS | 0.22% |
 TWIST BIOSCIENCE CORP | TWST | 0.22% |
 AMNEAL PHARMACEUTICALS INC | AMRX | 0.21% |
 TRAVERE THERAPEUTICS INC | TVTX | 0.2% |
 ORUKA THERAPEUTICS INC | ORKA | 0.2% |
 CRISPR THERAPEUTICS AG | CRSP | 0.2% |
 DEFINIUM THERAPEUTICS INC | DFTX | 0.2% |
 10X GENOMICS INC-CLASS A | TXG | 0.19% |
 INDIVIOR PHARMACEUTICALS INC | INDV | 0.19% |
 EDGEWISE THERAPEUTICS INC | EWTX | 0.19% |
 CARIS LIFE SCIENCES INC | CAI | 0.19% |
 VERACYTE INC | VCYT | 0.18% |
 TANGO THERAPEUTICS INC | TNGX | 0.17% |
 ACADIA PHARMACEUTICALS INC | ACAD | 0.17% |
 RELAY THERAPEUTICS INC | RLAY | 0.17% |
 STRUCTURE THERAPEUTICS INC | GPCR | 0.16% |
 NEWAMSTERDAM PHARMA CO NV | NEWAMSTERDAM.PHARMA.CO.NV | 0.16% |
 DENALI THERAPEUTICS INC | DNLI | 0.16% |
 DYNE THERAPEUTICS INC | DYN | 0.15% |
 ALUMIS INC | ALMS | 0.14% |
 ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.13% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 0.13% |
 BEAM THERAPEUTICS INC | BEAM | 0.13% |
 ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.13% |
 IDEAYA BIOSCIENCES INC | IDYA | 0.13% |
 ENLIVEN THERAPEUTICS INC | ELVN | 0.12% |
 GRAIL INC | GRAL | 0.12% |
 VERA THERAPEUTICS INC | VERA | 0.12% |
 KINIKSA PHARMACEUTICALS INTE | KNSA | 0.11% |
 DISC MEDICINE INC | IRON | 0.11% |
 MBX BIOSCIENCES INC | MBX | 0.11% |
 SUPERNUS PHARMACEUTICALS INC | SUPN | 0.11% |
 UNIQURE NV | QURE | 0.1% |
 BIOCRYST PHARMACEUTICALS INC | BCRX | 0.1% |
 KODIAK SCIENCES INC | KOD | 0.1% |
 TREVI THERAPEUTICS INC | TRVI | 0.1% |
 TARSUS PHARMACEUTICALS INC | TARS | 0.1% |
 AGIOS PHARMACEUTICALS INC | AGIO | 0.09% |
 PHARVARIS NV | PHVS | 0.09% |
 VERICEL CORP | VCEL | 0.09% |
 NURIX THERAPEUTICS INC | NRIX | 0.09% |
 MINERALYS THERAPEUTICS INC | MLYS | 0.09% |
 LEGEND BIOTECH CORP-ADR | LEGN | 0.09% |
 OCULAR THERAPEUTIX INC | OCUL | 0.09% |
 GENMAB A/S -SP ADR | GMAB | 0.09% |
 HARMONY BIOSCIENCES HOLDINGS | HRMY | 0.08% |
 ADMA BIOLOGICS INC | ADMA | 0.08% |
 SYNDAX PHARMACEUTICALS INC | SNDX | 0.08% |
 ABCELLERA BIOLOGICS INC | ABCL | 0.08% |
 SIONNA THERAPEUTICS INC | SION | 0.08% |
 AURINIA PHARMACEUTICALS INC | AUPH | 0.08% |
 SAREPTA THERAPEUTICS INC | SRPT | 0.08% |
 RAPPORT THERAPEUTICS INC | RAPP | 0.08% |
 INTELLIA THERAPEUTICS INC | NTLA | 0.08% |
 AMYLYX PHARMACEUTICALS INC | AMLX | 0.08% |
 STOKE THERAPEUTICS INC | STOK | 0.08% |
 TYRA BIOSCIENCES INC | TYRA | 0.08% |
 MONTE ROSA THERAPEUTICS INC | GLUE | 0.08% |
 ANAPTYSBIO INC | ANAB | 0.07% |
 ATAIBECKLEY INC | ATAI | 0.07% |
 BICARA THERAPEUTICS INC | BCAX | 0.07% |
 PRECIGEN INC | PGEN | 0.07% |
 IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.07% |
 ZYMEWORKS INC | ZYME | 0.07% |
 NOVOCURE LTD | NVCR | 0.07% |
 UROGEN PHARMA LTD | URGN | 0.07% |
 RECURSION PHARMACEUTICALS-A | RXRX | 0.07% |
 ANI PHARMACEUTICALS INC | ANIP | 0.07% |
 TAYSHA GENE THERAPIES INC | TSHA | 0.07% |
 ZENAS BIOPHARMA INC | ZBIO | 0.07% |
 COMPASS PATHWAYS PLC | CMPS | 0.07% |
 GH RESEARCH PLC | GHRS | 0.07% |
 MAZE THERAPEUTICS INC | MAZE | 0.07% |
 FORTREA HOLDINGS INC | FTRE | 0.07% |
 VIR BIOTECHNOLOGY INC | VIR | 0.07% |
 ABSCI CORP | ABSI | 0.06% |
 INNOVIVA INC | INVA | 0.06% |
 SEPTERNA INC | SEPN | 0.06% |
 HARROW INC | HROW | 0.06% |
 ARRIVENT BIOPHARMA INC | AVBP | 0.06% |
 NOVAVAX INC | NVAX | 0.06% |
 PERSONALIS INC | PSNL | 0.06% |
 XERIS BIOPHARMA HOLDINGS INC | XERS | 0.06% |
 IMMUNOCORE HOLDINGS PLC-ADR | IMCR | 0.06% |
 INHIBRX BIOSCIENCES INC | INBX | 0.05% |
 CORVUS PHARMACEUTICALS INC | CRVS | 0.05% |
 ARDELYX INC | ARDX | 0.05% |
 FIRST TRACKS BIOTHERAPEUTICS | TRAX | 0.05% |
 MANNKIND CORP | MNKD | 0.05% |
 MEIRAGTX HOLDINGS PLC | MGTX | 0.05% |
 SAVARA INC | SVRA | 0.05% |
 EYEPOINT INC | EYPT | 0.05% |
 WAVE LIFE SCIENCES LTD | WVE | 0.05% |
 XENCOR INC | XNCR | 0.05% |
 COLLEGIUM PHARMACEUTICAL INC | COLL | 0.04% |
 ORIC PHARMACEUTICALS INC | ORIC | 0.04% |
 CULLINAN THERAPEUTICS INC | CGEM | 0.04% |
 BIOAGE LABS INC | BIOA | 0.04% |
 SANA BIOTECHNOLOGY INC | SANA | 0.04% |
 OLEMA PHARMACEUTICALS INC | OLMA | 0.04% |
 VOR BIOPHARMA INC | VOR | 0.04% |
 SOLID BIOSCIENCES INC | SLDB | 0.04% |
 ALVOTECH SA | ALVO | 0.04% |
 KURA ONCOLOGY INC | KURA | 0.04% |
 PHATHOM PHARMACEUTICALS INC | PHAT | 0.04% |
 PACIRA BIOSCIENCES INC | PCRX | 0.04% |
 ETON PHARMACEUTICALS INC | ETON | 0.04% |
 JANUX THERAPEUTICS INC | JANX | 0.04% |
 GERON CORP | GERN | 0.04% |
 ANNEXON INC | ANNX | 0.04% |
 DESIGN THERAPEUTICS INC | DSGN | 0.04% |
 ARBUTUS BIOPHARMA CORP | ABUS | 0.04% |
 REPLIMUNE GROUP INC | REPL | 0.04% |
 MARAVAI LIFESCIENCES HLDGS-A | MRVI | 0.03% |
 GRIFOLS SA-ADR | GRFS | 0.03% |
 THERAVANCE BIOPHARMA INC | TBPH | 0.03% |
 AMPHASTAR PHARMACEUTICALS IN | AMPH | 0.03% |
 CYTOMX THERAPEUTICS INC | CTMX | 0.03% |
 MESOBLAST LTD- SPON ADR | MESO | 0.03% |
 ZEVRA THERAPEUTICS INC | ZVRA | 0.03% |
 ARS PHARMACEUTICALS INC | SPRY | 0.03% |
 RIGEL PHARMACEUTICALS INC | RIGL | 0.03% |
 ACLARIS THERAPEUTICS INC | ACRS | 0.03% |
 OMEROS CORP | OMER | 0.03% |
 IRONWOOD PHARMACEUTICALS INC | IRWD | 0.03% |
 CASTLE BIOSCIENCES INC | CSTL | 0.03% |
 REGENXBIO INC | RGNX | 0.03% |
 AURA BIOSCIENCES INC | AURA | 0.03% |
 CANDEL THERAPEUTICS INC | CADL | 0.03% |
 ALLOGENE THERAPEUTICS INC | ALLO | 0.03% |
 PRIME MEDICINE INC | PRME | 0.03% |
 PHIBRO ANIMAL HEALTH CORP-A | PAHC | 0.03% |
 ZAI LAB LTD-ADR | ZLAB | 0.03% |
 CORMEDIX INC | CRMD | 0.03% |
 TECTONIC THERAPEUTIC INC | TECX | 0.03% |
 4D MOLECULAR THERAPEUTICS IN | FDMT | 0.02% |
 NEUROGENE INC | NGNE | 0.02% |
 ALTIMMUNE INC | ALT | 0.02% |
 ARVINAS INC | ARVN | 0.02% |
 AQUESTIVE THERAPEUTICS INC | AQST | 0.02% |
 KYVERNA THERAPEUTICS INC | KYTX | 0.02% |
 EDITAS MEDICINE INC | EDIT | 0.02% |
 CONTINEUM THERAPEUTICS INC-A | CTNM | 0.02% |
 PACIFIC BIOSCIENCES OF CALIF | PACB | 0.02% |
 CABALETTA BIO INC | CABA | 0.02% |
 PROTHENA CORP PLC | PRTA | 0.02% |
 LAKEFRONT BIOTHERAPEUTIC-ADR | LKFT | 0.02% |
 SAGIMET BIOSCIENCES INC-A | SGMT | 0.02% |
 C4 THERAPEUTICS INC | CCCC | 0.02% |
 LARIMAR THERAPEUTICS INC | LRMR | 0.02% |
 EVOLUS INC | EOLS | 0.02% |
 SILENCE THERAPEUTICS PLC-ADR | SLN | 0.02% |
 ROCKET PHARMACEUTICALS INC | RCKT | 0.02% |
 KAMADA LTD | KMDA | 0.02% |
 UPSTREAM BIO INC | UPB | 0.02% |
 PUMA BIOTECHNOLOGY INC | PBYI | 0.02% |
 ATEA PHARMACEUTICALS INC | AVIR | 0.02% |
 ENANTA PHARMACEUTICALS INC | ENTA | 0.02% |
 LEXEO THERAPEUTICS INC | LXEO | 0.01% |
 VANDA PHARMACEUTICALS INC | VNDA | 0.01% |
 LYELL IMMUNOPHARMA INC | LYEL | 0.01% |
 FOGHORN THERAPEUTICS INC | FHTX | 0.01% |
 OMNIAB INC | OABI | 0.01% |
 IMMUNEERING CORP - CLASS A | IMRX | 0.01% |
 AUTOLUS THERAPEUTICS PLC | AUTL | 0.01% |
 NEUMORA THERAPEUTICS INC | NMRA | 0.01% |
 ALPHA TEKNOVA INC | TKNO | 0.01% |
 ENTRADA THERAPEUTICS INC | TRDA | 0.01% |
 SIGA TECHNOLOGIES INC | SIGA | 0.01% |
 AC IMMUNE SA | ACIU | 0.01% |
 ORCHESTRA BIOMED HOLDINGS IN | OBIO | 0.01% |
 COHERUS ONCOLOGY INC | CHRS | 0.01% |
 KEROS THERAPEUTICS INC | KROS | 0.01% |
 FULCRUM THERAPEUTICS INC | FULC | 0.01% |
 ANAVEX LIFE SCIENCES CORP | AVXL | 0.01% |
 INVIVYD INC | IVVD | 0.01% |
 CODEXIS INC | CDXS | 0.01% |
 NOVABRIDGE BIOSCIENCES | NBP | 0.01% |
 VOYAGER THERAPEUTICS INC | VYGR | 0.01% |
 BICYCLE THERAPEUTICS PLC-ADR | BCYC | 0.01% |
 ARCTURUS THERAPEUTICS HOLDIN | ARCT | 0.01% |
 CARIBOU BIOSCIENCES INC | CRBU | 0.01% |
 TENAYA THERAPEUTICS INC | TNYA | 0.01% |
 LIFECORE BIOMEDICAL INC | LFCR | 0.01% |
 LENZ THERAPEUTICS INC | LENZ | 0.01% |
 QUANTUM-SI INC | QSI | 0.01% |
 PYXIS ONCOLOGY INC | PYXS | 0.01% |
 JYONG BIOTECH LTD | MENS | 0.01% |
 AARDVARK THERAPEUTICS INC | AARD | 0.01% |
 PEPGEN INC | PEPG | 0.01% |
 HUMACYTE INC | HUMA | 0.01% |
 BLACK DIAMOND THERAPEUTICS I | BDTX | 0% |
 RANI THERAPEUTICS HOLDINGS-A | RANI | 0% |
 GOSSAMER BIO INC | GOSS | 0% |
 NASDAQ Biotechnology Index SWAP Citibank NA | NASDAQ.Biotechnology.Index.SWAP.Citibank.NA | 0% |
 NASDAQ Biotechnology Index SWAP Societe Generale | NASDAQ.Biotechnology.Index.SWAP.Societe.Generale | 0% |
 NASDAQ Biotechnology Index SWAP UBS AG | NASDAQ.Biotechnology.Index.SWAP.UBS.AG | 0% |
 THIRD HARMONIC BIO INC | THRD | 0% |
 NASDAQ Bio Index SWAP BNP Paribas | NASDAQ.Bio.Index.SWAP.BNP.Paribas | 0% |
 NASDAQ Biotechnology Index SWAP Bank of America NA | NASDAQ.Biotechnology.Index.SWAP.Bank.of.America.NA | 0% |
 NASDAQ Biotechnology Index SWAP Goldman Sachs International | NASDAQ.Biotechnology.Index.SWAP.Goldman.Sachs.International | 0% |
 CARTESIAN THERAPEUTICS-CVR | CARTESIAN.THERAPEUTICS.CVR | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
ProShares Ultra Nasdaq Biotechnology (BIB) share price today is $102.9242.
Yes, Indians can buy shares of ProShares Ultra Nasdaq Biotechnology (BIB) on Vested. To buy BIB from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ProShares Ultra Nasdaq Biotechnology (BIB) on Vested. You can start investing in ProShares Ultra Nasdaq Biotechnology (BIB) with a minimum investment of $1.
The 52-week high price of ProShares Ultra Nasdaq Biotechnology (BIB) is $110.25. The 52-week low price of ProShares Ultra Nasdaq Biotechnology (BIB) is $48.27.
The stock symbol (or ticker) of ProShares Ultra Nasdaq Biotechnology is BIB.
Yes, you can setup SIP in ProShares Ultra Nasdaq Biotechnology shares. Follow the below steps to create the SIP:
Here is the historical performance of BIB on the Vested app.
The expense ratio of ProShares Ultra Nasdaq Biotechnology (BIB) is 0.95%.
Link copied 
